Dexmedetomidine: A Novel Premedicant in RSI - A Clinical Study Conducted in a Tertiary Care Institution in South India
Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 4
Abstract
Background: Patients often require a rapid sequence induction (RSI) endotracheal intubation technique during emergency ophthalmic surgeries which is often a nightmare to the anaesthesiologists as patients with penetrating eye injury often present with full stomach. Traditionally succinylcholine has been the most commonly used muscle relaxant for this purpose because of its fast onset and short duration; unfortunately, it can have serious side effects like increased intraocular pressure. Various drugs like sufentanil and clonidine has been studied in an attempt to use as a premedicant for blunting the rise in intraocular pressure with varying results. Dexmedetomidine is a selective alpha-2 adrenergic agonist that has IOP-lowering properties along with sedative and analgesic effects. Studies have shown dexmedetomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery. Aim: To determine the effect of dexmedetomidine in the prevention of rise of IOP by succinylcholine during RSI intubation Methods: 70 patients who are undergoing elective non ophthalmic surgery have been enrolled in this study. Adult patients in the age group 20-65 years weighing 60-80 kg of either sex falling under ASA I / II of American Society Of Anaesthesiologists (ASA) physical status classification. We collected the data using structured proforma and interpreted using Ramsay sedation scale, Schiotz tonometry for measuring IOP. Results: Dexmedetomidine as a premedicant in patients undergoing surgeries under GA was found to reduce the IOP by 34% after a single i.v. dose of dexmedetomidine ( 0.6 mg/kg). Additionally, the pressor response to laryngoscopy and endotracheal intubation was also significantly attenuated Conclusions: Premedication with intravenous Dexmedetomidine under the dose given in the present study design attenuates the rise in intraocular pressure following succinylcholine and intubation. The attenuation of haemodynamic stress response to laryngoscopy and intubation is an additional advantage. Hence dexmedetomidine could be used as a premedicant in situations where an increase in intraocular pressure following succinylcholine and intubation is prejudicial for patients.
Authors and Affiliations
Beula G
Keywords
Related Articles
- EP ID EP284387
- DOI -
- Views 94
- Downloads 0
Management of Natal and Neonatal tooth: A series of Three rare Cases
The presence of teeth at birth (natal teeth) or within a month after delivery (neonatal teeth) is a rare condition. The teeth are often small, conical and yellowish and have hypoplastic enamel and dentin with poor or abs...
Masking the Drawbacks of Surgical Closure of Failed Oroantral Fistula Correction with a Partial Denture Prosthesis
Proximity of maxillary sinus with the maxillary posterior teeth makes it vulnerable to be exposed during difficult extractions. When the sinus is exposed during extraction it is usually closed by surgery. Many times thes...
Awareness about Mosquito Borne Diseases and Practice about Preventive Methods Against Mosquito Bite in Rural Field Practice Area of a Tertiary Care Teaching Institute, Telangana State
Background: Mosquitoes can transmit various diseases like Malaria, Filaria, Japanese Encephalitis, Dengue and Chikungunya. Awareness about the risk of mosquito bite and source reduction can prevent the transmission of th...
Comparison of Different Doses of Clonidine as an Adjuvant to Intrathecal Bupivacaine for Spinal Anaesthesia in Patients Undergoing Lower Limb Orthopedic Surgery
Background: Clonidine is added to local anaesthetics as adjuvant in spinal anaesthesia to improve quality and duration of sensory and motor block. Dose of Clonidine used is varied from 15μg to 150 μg and most of the stud...
Predictors of Need for Non-Invasive Mechanical Ventilation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Background: COPD remains a common cause of morbidity and mortality worldwide. NIV has been well established as the gold standard therapy for treatment of acute decompensated respiratory failure complicating an acute exac...